Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Liabilities (2021 - 2025)

Rxo (RXO) has disclosed Total Liabilities for 5 consecutive years, with -$1.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 185.52% year-over-year to -$1.5 billion, compared with a TTM value of -$1.5 billion through Dec 2025, down 185.52%, and an annual FY2025 reading of -$1.5 billion, down 185.52% over the prior year.
  • Total Liabilities was -$1.5 billion for Q4 2025 at Rxo, down from $1.6 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.8 billion in Q4 2024 and bottomed at -$1.5 billion in Q4 2025.
  • Average Total Liabilities over 5 years is $943.5 million, with a median of $1.3 billion recorded in 2023.
  • The sharpest move saw Total Liabilities soared 237.39% in 2023, then crashed 185.52% in 2025.
  • Year by year, Total Liabilities stood at $998.0 million in 2021, then skyrocketed by 44.69% to $1.4 billion in 2022, then decreased by 14.75% to $1.2 billion in 2023, then surged by 46.39% to $1.8 billion in 2024, then plummeted by 185.52% to -$1.5 billion in 2025.
  • Business Quant data shows Total Liabilities for RXO at -$1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.